Quantitative estimation of drugs for erectile dysfunction and benign prostatic hyperplasia by high performance liquid chromatography: a review

Shalaka G. Gaonkar; Basavaraj M. Dinnimath

doi:10.22456/2527-2616.143081

Authors

Shalaka G. Gaonkar Department of Pharmaceutical Chemistry - KLE College of Pharmacy https://orcid.org/0009-0007-7369-9907
Basavaraj M. Dinnimath Department of Pharmaceutical Chemistry - KLE College of Pharmacy https://orcid.org/0000-0001-6092-3606

DOI:

https://doi.org/10.22456/2527-2616.143081

Keywords:

High performance liquid chromatography, erectile dysfunction, benign prostatic hyperplasia, chromatographic conditions, simultaneous estimation

Abstract

This review article explores the critical application of High-Performance Liquid Chromatography (HPLC) in analyzing medications for Erectile Dysfunction (ED) and Benign Prostatic Hyperplasia (BPH). HPLC is essential for the precise measurement of these drugs, whether assessed individually or within combination therapies. The review thoroughly examines various HPLC methodologies, encompassing both single-drug and simultaneous analysis techniques. It addresses the optimization of HPLC conditions and validation practices necessary for achieving reliable results. Key challenges in HPLC analysis are highlighted, including sensitivity issues and the need for specific adjustments in analytical procedures. The article discusses the influence of factors such as column types, mobile phases, and detection methods on HPLC performance. It offers detailed insights into optimizing parameters to enhance resolution and accuracy, providing practical guidance for researchers working with ED and BPH drugs. Moreover, the review outlines best practices for validating HPLC methods according to regulatory standards, which are crucial for maintaining the quality and reproducibility of analytical results. It also identifies potential areas for improvement, including enhancing method sensitivity and reducing analysis time. By emphasizing the importance of HPLC in maintaining high analytical standards for ED and BPH drug analysis, this review serves as a valuable resource for researchers, clinicians, and pharmaceutical companies, ultimately aiming to enhance drug management and improve patient outcomes through better analytical practices and innovative approaches.

Downloads

Download data is not yet available.

References

Calogero AE, Burgio G, Condorelli RA, Cannarella R, La Vignera S. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male. 2019 Jan 2;22(1):12-9.

Dabhi TK, Vaghela VM. A review on analytical method development for simultaneous estimation and validation of finasteride and tadalafil. World Journal of Pharmaceutical Research. 2023 Apr 15;12(9):1204-1231.

Andrea Sansone, Béatrice Cuzin, Emmanuele A. Jannini. Facing counterfeit medications in sexual medicine. a systematic scoping review on social strategies and technological solutions. Sexual Medicine. 2021 Dec;9(6):100437.

Mazzilli F. Erectile dysfunction: causes, diagnosis and treatment: an update. Journal of Clinical Medicine. 2022 Oct 30;11(21):6429.

Li Y, Ma J, Qin XH, Hu CY. The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and metaanalysis. Translational Andrology and Urology. 2022 Mar;11(3):313-324.

Chaudhari A, Patel B, Mashru R. Development and validation of stability indicating RP-HPLC and spectrophotometry for simultaneous estimation of sildenafil citrate and fluoxetine in bulk & tablet dosage form. World Journal of Pharmaceutical Research. 2017 May 10;6(7):1129-40.

Dural E. Investigation of the presence of sildenafil in herbal dietary supplements by validated HPLC method. Turkish journal of pharmaceutical sciences. 2020 Feb;17(1):56.

Abdelshakour MA, Salam RA, Hadad GM, AboElMatty DM, Hameed EA. HPLC-UV and UPLCMS/MS methods for the simultaneous analysis of sildenafil, vardenafil, and tadalafil and their counterfeits dapoxetine, paroxetine, citalopram, tramadol, and yohimbine in aphrodisiac products. RSC advances. 2021 Feb 3;11(14):8055-64.

Hossain CF, Al-Amin M, Sultana GN. Use of HPLC with a photodiode array detector to identify sildenafil citrate as an adulterant in herbal products of bangladesh. Novel Aspects on Pharmaceutical Research.2023;4:18-27.

Smerikarova M, Bozhanov ST, Maslarska V. HPLC determination of sildenafil in tablets. International Journal of Applied Pharmaceutics. 2021 Jan 7;13(1).

Ravisankar P, Anusha S, Chowdary AD, Krishna PS. An improved RP-HPLC method for the quantitative determination and validation of sildenafil citrate in bulk and pharmaceutical formulation. International Journal of Pharmaceutical Sciences Review and Research. 2019 Jan 4; 54(1):75-82.

Tama AL, Musa A, Usman MA, Awwalu S. Evaluation of sildenafil as an undeclared adulterant in herbal aphrodisiac preparations by HPLC. Saudi Journal of Medical and Pharmaceutical Sciences. 2020 Feb 8;6(2):168-172.

Dahshan HE, Helal MA, Mostafa SM, Elgawish MS. Development and validation of an HPLC-UV method for simultaneous determination of sildenafil and tramadol in biological fluids: Application to drugdrug interaction study. Journal of pharmaceutical and biomedical analysis. 2019 May 10;168:201-8.

Kamal A, Mabrouk MM, Hammad SF, Soliman B. Isocratic RP-HPLC method for detection of sildenafil in some marketed dietary supplements. Journal of Advanced Medical and Pharmaceutical Research. 2024 Jul 6;05:82-91.

Kumar A, Kumar V, Singh RM, Chaudhari J, Kori P. Reverse phase–high performance liquid chromatographic method for simultaneous estimation of sildenafil citrate and tadalafil in tablets dosage form. International Journal for Advance Research and Development. 2018 Apr 27;3(4):326-30.

Shen X, Chen F, Wang F, Huang P, Luo W. The effect of grapefruit juice on the pharmacokinetics of tadalafil in rats. BioMed Research International. 2020 Jan 25;2020(1):1631735.

Shimpi PS, Mahajan HS. Bioanalytical method development and validation of tadalafil in human plasma using RP-HPLC. World Journal of Pharmaceutical Research. 2020 Jun 6;9(8):902-916.

Madane VA, Bhatia NM, Bhagwat DA. Development and validation of RP-HPLC method for estimation of tadalafil. World Journal of Pharmacy and Pharmaceutical Sciences. 2020 Dec 28;10(3): 1302-1309.

Pinto MA, Nicorena KF, Machado MM, Oliveira LF, Paim CS, Silva FE, Malesuik MD. Tadalafil and sildenafil illicit association: stability-indicating HPLC method, photodegradation kinetic and toxicological studies. Brazilian Journal of Pharmaceutical Sciences. 2022 Jul 1;58:19491.

Kammoun AK, Khayat MT, Almalki AJ, Youssef RM. Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools. RSC advances. 2023 Apr 17;13(17):11817-25.

Vyas AJ, Gol DA, Patel AI, Patel AB, Patel NK, Chavda JR, Lumbhani A, Chudasama A. Implementing analytical quality by design (AQbD) approach for simultaneous estimation of tadalafil and macitentan by RP-HPLC method. Analytical Chemistry Letters. 2021 Jul 4;11(4):539-52.

Patil PH, Gurupadayya B, Hamrapurkar P. Integrated quality by design (QbD) approach for stability indicating RPHPLC method for the estimation of tadalafil hydrochloride in bulk drug and pharmaceutical formulations. Current Pharmaceutical Analysis. 2021 Aug 1;17(7):932-44.

Yadav S, Sharma N. Development of reverse phase high performance liquid chromatography method for simultaneous estimation of sildenafil citrate and depoxetine hydrochloride in pharmaceutical formulation. Current Research in Pharmaceutical Sciences. 2022 Apr 6;12(1):28-31.

Shafaat SW, Ahmed A, Khan SS, Jabbar MA. Analytical Method Development and validation of simultaneous estimation of ambrisentan and tadalafil in bulk and pharmaceutical dosage form by HPLC. International Research Journal of Engineering and Technology. 2022 Feb;9(2):156-161.

Kumar N, Sangeetha D, Kalyanraman L, Sainath K. Stability-indicating HPLC method for simultaneous determination of degradation products and processrelated impurities of avanafil in avanafil tablets. Acta Chromatographica. 2018 Sep 1;30(3):158-63.

Jadhav MV, Akash A, Munipalli V, Singh RM, Nayak S, Vaidhun B. Development and validation of reverse phase high performance liquid chromatography method for quantitative estimation of avanafil in tablet dosage form. Journal of Pharma Innovation. 2020;1(1):29-37.

Gandla K, Lalitha R, Kumar DV, Shruthi PV. Bioanalytical method development and validation of vardenafil in human plasma using RP-HPLC. International Journal of Indigenous Herbs and Drugs. 2020 Feb 29:7-16.

Zaharieva Z, Tanev D, Danalev D. Development and validation of HPLC/DAD method for simultaneously determination of six prohibited substances in model matrices. Acta Chromatographica. 2020 Dec 1;32(4):276-80.

Nagaraju P, Prasad BD, Priyadarshini GI. Development and validation of a reversed phase HPLC method for simultaneous determination of tamsulosin and dutasteride in tablet dosage form. Advance Pharmaceutical Journal. 2017 Aug 5;2(4):134-8.

Boltia SA, Abdelkawy M, Mohamed TA, Mostafa NN. Eco-friendly RP-HPLC and HPTLC methods for simultaneous determination of tamsulosin hydrochloride and deflazacort in the presence of 21- hydroxy deflazacort and testing the in-vitro dissolution of the combined dosage form via RPHPLC method. Chromatographia. 2021 Feb 2;84(3):285-95.

Chandrasekhar K, Manikandan A. Novel RP-HPLC method development and validation of Tamsulosin hcl and dutasteride in tablets by ratio’s method. Rasayan Journal of Chemistry. 2021 Apr 1;14(2):665-71.

Rupapara VV, Dedania ZR, Dedania. HPLC method development and validation of deflazacort and tamsulosin hydrochloride in combined dosage form. World Journal of Pharmaceutical Research. 2018 Jun 5;7(15):526-537.

Al-Shammari WT, Al-Ogaidi AJ. Determination of active ingredient in tamsulosin drug by using HPLC. Iraqi Journal of Agricultural Sciences. 2022 Jun 29;53(3):561-9.

Kailashreddy MV, Thejomoorthy K, Saibabu CH. Development and validation of a stability indicating RP-HPLC method for the estimation of dutasteride and tamsulosin hydrochloride in pharmaceutical formulations. International Research Journal of Modernization in Engineering Technology and Science. 2023 Jul;5(7):2345-56.

Mishra MR, Bakshe MP, Patil MH, Chaudhari RY, Patil VR. Development and validation of RP HPLC method for the estimation of alfuzosin in tablet formulation. International Journal of Pharmaceutics and Drug Analysis. 2017 Mar 7;5(3):43-8.

Satpute PD, Jadhav SB, Rathod MP, Naykodi PS. RP-HPLC Forced degradation study of alfuzosin and dutasteride. Pharmaceutical Resonance.2018; 1(1):21-25.

Wadie M, Abdel-Moety EM, Rezk MR, Tantawy MA. Eco-friendly chiral HPLC method for determination of alfuzosin enantiomers and solifenacin in their newly pharmaceutical combination: Method optimization via central composite design. Microchemical Journal. 2021 Jun 1;165:106095.

Tantawy M, Weshahy S, Wadie M, Rezk MR. A novel HPLC-DAD method for simultaneous determination of alfuzosin and solifenacin along with their official impurities induced via a stress stability study; investigation of their degradation kinetics Analytical Methods. The Royal Society of Chemistry. 2020 Jun 19;12(26): 3368-75.

Krotz D, Mengesha AE. Development and validation of a reversed-phase HPLC method for simultaneous determination of doxazosin mesylate and finasteride. Acta Chromatographica. 2017 Sep 1;29(3):309-24.

Monir HH, Ali AM, Refat RE, Abbas SS. Chromatographic methods for determination of finasteride and tamsulosin hydrochloride and in presence of finasteride degradation product. Acta Chromatographica. 2020 Jun 1;32(2):95-101.

Nemane ST, Gholve SB, Bhusnure OG, Mane SR, Surwase PP, Karwa PN. Development and validation of a RP-HPLC method for determination of finasteride in pharmaceutical dosage forms. World Journal of Pharmaceutical Research. 2019 Nov 27;9(2):883-895.

Dhiman S, Kurmi BD, Asati V. Analytical reversed‐ phase high‐performance liquid chromatography method development for silodosin and solifenacin in bulk and marketed formulation using analytical quality by design approach. Separation Science Plus. 2023 Feb;6(2):2200117.

Jagadeesh K, Kadiyala KG, Varma Dendukuri BN, Guttula RS, Gupta Tiruveedhi VL, Vamsi PE. Quality control assessment of dutasteride and silodosin in capsules and tablets employing a novel developed HPLC technique; evaluation of stabilities of dutasteride and silodosin in accelerated degradation. International Journal of Applied Pharmaceutics. 2023 Sep 12;15(6):98-107.

Paljashuva K, Ramarao N. Simultaneous estimation of dutasteride and silodosin in bulk form by RPHPLC method. World Journal of Current Medical and Pharmaceutical Research. 2019 Oct 31;1(5):148- 163.

Deshmukh AV, Shirode MA, Kadam VJ. Analytical method development and validation for the quantitative estimation of dutasteride in its tablet dosage form by RP-HPLC method. International Journal of Creative Research Thoughts. 2021 Jun;9(6):120-133.

Ali M, Sharma DK. A new method development and validation of 5a reductase inhibitor (dutasteride) using R-HPLC in bulk and pharmaceutical dosage form (dexamethasone use as an internal standard). Journal of Advanced Zoology. 2023 Dec 1;44(5):244-261.

Prasad YR. Determination of dutasteride for analytical method development and validation in bulk as well as in pharmaceutical dosage form by using RP-HPLC. World Journal of Pharmaceutical Sciences. 2022 Sep 5;10(09):61-69.

Diyya K. Novel stability indicating RP-HPLC method development and validation for simultaneous estimation of alfuzosin and dutasteride in pharmaceutical dosage form. Indian Journal of Pharmaceutical Education and Research.2020 Oct 1;54(4):1144-52.

Wadie M, Abdel-Moety EM, Rezk MR, Marzouk HM. A novel eco-friendly HPLC method with dual detection modes for versatile quantification of dutasteride and silodosin in pharmaceutical formulation, dissolution testing and spiked human plasma. Microchemical Journal. 2024 Feb 1;197:109753.

Walash MI, Belal F, Fathy ME, Borg H. Simultaneous HPLC determination of four α-blocker drugs using time programming technique. Analytical Chemistry Letters. 2017 Jul 4;7(4):531-44.

Bika S, Purohit P, Aggarwal Y. Analytical method development and validation of naftopidil in bulk and dosage form using RP HPLC. World Journal of Pharmaceutical Research. 2017 Jul 7; 6(10):792-805.

Dinnimath BM, Jalalpure SS. Validation of new liquid chromatographic method for naturally isolated quercetin and its commercial application to ayurvedic formulation. Indian drugs. 2019 Jun 1;56(6):46-50.

Kudatarkar N, Jalalpure SS, Singadi R, GuraoR , Dinnimath BM . Development and validation Of UVVisible spectrophotometric method for estimation of chrysin in bulk form. Journal of Pharmaceutical Negative Results. 2022;13(8)